PCV30 Analysis of Generic Simvastatin and Atorvastatin Versus Branded Rosuvastatin in Hyperlipidemia Patients- A Budget Impact Model from a Managed Care Organization Perspective in the United States
Abstract
Authors
L. Ruff C. Montouchet S. Balu